{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:42:18Z","timestamp":1782520938106,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"U.S. National Library of Medicine,United States","award":["K01LM012870"],"award-info":[{"award-number":["K01LM012870"]}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD02528"],"award-info":[{"award-number":["HD02528"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heritable connective tissue disorders (HCTDs) consist of heterogeneous syndromes. The diagnosis of HCTDs is aided by genomic biotechnologies (e.g., next-generation sequencing panels) facilitating the discovery of novel variants causing disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Detailed clinical exam data and CLIA-approved genetic testing results from next generation sequencing of 74 genes known to play a role in HCTDs were manually reviewed and analyzed in one hundred consecutive, unrelated patients with phenotypic features indicative of a HCTD referred over a 3.5-year period (2016\u20132020) to a specialized academic genetics clinic. The prevalence of symptoms was evaluated in the context of genetic variants. We also determined if symptoms among different organ systems were related and performed latent class analysis to identify distinct groups of patients based on symptomatology.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the cohort of 100 consecutive, unrelated individuals there were four pathogenic, six likely pathogenic and 35 classified potentially pathogenic variants of unknown clinical significance. Patients with potentially pathogenic variants exhibited similar symptom profiles when compared to patients with pathogenic\/likely pathogenic variants in the same genes. Although results did not meet a multiple testing corrected threshold, patients with connective tissue symptoms had suggestive evidence of increased odds of having skin (odds ratio 2.18, 95% confidence interval 1.12 to 4.24) and eye symptoms (odds ratio 1.89, 95% confidence interval 0.98 to 3.66) requiring further studies. The best performing latent class analysis results were identified when dividing the dataset into three distinct groups based on age, gender and presence or absence of symptoms in the skeletal, connective tissue, nervous, gastrointestinal and cardiovascular systems. These distinct classes of patients included individuals with: (1) minimal skeletal symptoms, (2) more skeletal but fewer connective tissue, nervous or gastrointestinal symptoms and (3) more nervous system symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We used novel approaches to characterize phenotype-genotype relationships, including pinpointing potentially pathogenic variants, and detecting unique symptom profiles in patients with features of HCTDs. This study may guide future diagnosis and disease\/organ system monitoring with continued improvement and surveillance by clinicians for patients and their families.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-022-01321-w","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T09:06:23Z","timestamp":1659431183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical genetics evaluation and testing of connective tissue disorders: a cross-sectional study"],"prefix":"10.1186","volume":"15","author":[{"given":"Olivia J.","family":"Veatch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Steinle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waheeda A.","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merlin G.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"issue":"4","key":"1321_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ajmg.a.61054","volume":"179","author":"R Bascom","year":"2019","unstructured":"Bascom R, Schubart JR, Mills S, Smith T, Zukley LM, Francomano CA, et al. Heritable disorders of connective tissue: description of a data repository and initial cohort characterization. Am J Med Genet A. 2019;179(4):552\u201360.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"1321_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/1591019916659262","volume":"22","author":"ST Kim","year":"2016","unstructured":"Kim ST, Brinjikji W, Lanzino G, Kallmes DF. Neurovascular manifestations of connective-tissue diseases: a review. Interv Neuroradiol. 2016;22(6):624\u201337.","journal-title":"Interv Neuroradiol"},{"key":"1321_CR3","doi-asserted-by":"publisher","unstructured":"Wheeler JB, Ikonomidis JS, Jones JA. Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling. In: Halper J, editor. Progress in heritable soft connective tissue diseases. Dordrecht: Springer Netherlands; 2014. p. 107\u201327. (Advances in Experimental Medicine and Biology; vol. 802). https:\/\/doi.org\/10.1007\/978-94-007-7893-1_8","DOI":"10.1007\/978-94-007-7893-1_8"},{"issue":"6","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.21037\/acs.2017.11.03","volume":"6","author":"JAN Meester","year":"2017","unstructured":"Meester JAN, Verstraeten A, Schepers D, Alaerts M, Van Laer L, Loeys BL. Differences in manifestations of Marfan syndrome, Ehlers\u2013Danlos syndrome, and Loeys-Dietz syndrome. Ann Cardiothorac Surg. 2017;6(6):582\u201394.","journal-title":"Ann Cardiothorac Surg"},{"issue":"13","key":"1321_CR5","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.7150\/ijms.60685","volume":"18","author":"Q Du","year":"2021","unstructured":"Du Q, Zhang D, Zhuang Y, Xia Q, Wen T, Jia H. The molecular genetics of Marfan syndrome. Int J Med Sci. 2021;18(13):2752\u201366.","journal-title":"Int J Med Sci"},{"key":"1321_CR6","doi-asserted-by":"crossref","unstructured":"Claeys L, Storoni S, Eekhoff M, Elting M, Wisse L, Pals G, et al. Collagen transport and related pathways in Osteogenesis Imperfecta. Hum Genet. 2021.","DOI":"10.1007\/s00439-021-02302-2"},{"issue":"4","key":"1321_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng1119","volume":"33","author":"SP Robertson","year":"2003","unstructured":"Robertson SP, Twigg SRF, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, et al. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet. 2003;33(4):487\u201391.","journal-title":"Nat Genet"},{"issue":"1","key":"1321_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cge.13865","volume":"99","author":"A Beyens","year":"2021","unstructured":"Beyens A, Boel A, Symoens S, Callewaert B. Cutis laxa: a comprehensive overview of clinical characteristics and pathophysiology. Clin Genet. 2021;99(1):53\u201366.","journal-title":"Clin Genet"},{"issue":"2","key":"1321_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/genes12020183","volume":"12","author":"TJ Creamer","year":"2021","unstructured":"Creamer TJ, Bramel EE, MacFarlane EG. Insights on the pathogenesis of aneurysm through the study of hereditary aortopathies. Genes. 2021;12(2):183.","journal-title":"Genes"},{"key":"1321_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4966","volume":"18","author":"N Ghali","year":"2019","unstructured":"Ghali N, Sobey G, Burrows N. Ehlers\u2013Danlos syndromes. BMJ. 2019;18: l4966.","journal-title":"BMJ"},{"key":"1321_CR11","doi-asserted-by":"publisher","first-page":"472.e9","DOI":"10.1016\/j.avsg.2019.05.057","volume":"61","author":"SL Olson","year":"2019","unstructured":"Olson SL, Murray ML, Skeik N. A novel frameshift COL3A1 variant in vascular Ehlers\u2013Danlos syndrome. Ann Vasc Surg. 2019;61:472.e9-472.e13.","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"1321_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5496\/wjmg.v6.i2.17","volume":"6","author":"CS Kaufman","year":"2016","unstructured":"Kaufman CS, Butler MG. Mutation in TNXB gene causes moderate to severe Ehlers\u2013Danlos syndrome. World J Med Genet. 2016;6(2):17.","journal-title":"World J Med Genet"},{"issue":"1","key":"1321_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/ahg.12403","volume":"85","author":"V Madhuri","year":"2021","unstructured":"Madhuri V, Selina A, Loganathan L, Kumar A, Kumar V, Raymond R, et al. Osteogenesis imperfecta: novel genetic variants and clinical observations from a clinical exome study of 54 Indian patients. Ann Hum Genet. 2021;85(1):37\u201346.","journal-title":"Ann Hum Genet"},{"issue":"1","key":"1321_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers\u2013Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8\u201326.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"11","key":"1321_CR15","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/gtmb.2019.0064","volume":"23","author":"MK Pope","year":"2019","unstructured":"Pope MK, Ratajska A, Johnsen H, Rypdal KB, Sejersted Y, Paus B. Diagnostics of hereditary connective tissue disorders by genetic next-generation sequencing. Genet Test Mol Biomark. 2019;23(11):783\u201390.","journal-title":"Genet Test Mol Biomark"},{"issue":"5","key":"1321_CR16","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3390\/genes11050574","volume":"11","author":"T Grange","year":"2020","unstructured":"Grange T, Aubart M, Langeois M, Benarroch L, Arnaud P, Milleron O, et al. Quantifying the genetic basis of Marfan syndrome clinical variability. Genes. 2020;11(5):574.","journal-title":"Genes"},{"issue":"12","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41431-018-0164-9","volume":"26","author":"M Aubart","year":"2018","unstructured":"Aubart M, Gazal S, Arnaud P, Benarroch L, Gross M-S, Buratti J, et al. Association of modifiers and other genetic factors explain Marfan syndrome clinical variability. Eur J Hum Genet EJHG. 2018;26(12):1759\u201372.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"1","key":"1321_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-020-01554-6","volume":"39","author":"G Federici","year":"2020","unstructured":"Federici G, Soddu S. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers. J Exp Clin Cancer Res CR. 2020;39(1):46.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"1321_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i10","volume":"42","author":"DA Linzer","year":"2011","unstructured":"Linzer DA, Lewis JB. poLCA: an R package for polytomous variable latent class analysis. J Stat Softw. 2011;42:1\u201329.","journal-title":"J Stat Softw"},{"issue":"6","key":"1321_CR20","first-page":"383","volume":"8","author":"PH Byers","year":"2006","unstructured":"Byers PH, Krakow D, Nunes ME, Pepin M. American college of medical genetics. Genetic evaluation of suspected osteogenesis imperfecta (OI). Genet Med Off J Am Coll Med Genet. 2006;8(6):383\u20138.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"7","key":"1321_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/sj.jid.5700201","volume":"126","author":"O Le Saux","year":"2006","unstructured":"Le Saux O, Bunda S, VanWart CM, Douet V, Got L, Martin L, et al. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol. 2006;126(7):1497\u2013505.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1321_CR22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/BF00284038","volume":"82","author":"A Superti-Furga","year":"1989","unstructured":"Superti-Furga A, Steinmann B, Ramirez F, Byers PH. Molecular defects of type III procollagen in Ehlers\u2013Danlos syndrome type IV. Hum Genet. 1989;82(2):104\u20138.","journal-title":"Hum Genet"},{"issue":"2","key":"1321_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ajhg.2011.12.004","volume":"90","author":"M Baumann","year":"2012","unstructured":"Baumann M, Giunta C, Krabichler B, R\u00fcschendorf F, Zoppi N, Colombi M, et al. Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss. Am J Hum Genet. 2012;90(2):201\u201316.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"1321_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ajmg.a.30529","volume":"133A","author":"C Giunta","year":"2005","unstructured":"Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers\u2013Danlos syndrome (EDS VIA). Am J Med Genet A. 2005;133A(2):158\u201364.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"1321_CR25","first-page":"881","volume":"16","author":"MG Pepin","year":"2014","unstructured":"Pepin MG, Schwarze U, Rice KM, Liu M, Leistritz D, Byers PH. Survival is affected by mutation type and molecular mechanism in vascular Ehlers\u2013Danlos syndrome (EDS type IV). Genet Med Off J Am Coll Med Genet. 2014;16(12):881\u20138.","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"1321_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3389\/fpsyg.2014.00920","volume":"5","author":"IC Wurpts","year":"2014","unstructured":"Wurpts IC, Geiser C. Is adding more indicators to a latent class analysis beneficial or detrimental? Results of a Monte-Carlo study. Front Psychol. 2014;5:920.","journal-title":"Front Psychol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-022-01321-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-022-01321-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T09:11:03Z","timestamp":1659431463000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-022-01321-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1186\/s12920-022-01321-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study participants provided informed written consent for research use of de-identified clinical information and genetic testing results. All methods were carried out in accordance with relevant guidelines and regulations. All data collection protocols were approved by Fulgent Genetics, Inc. (, CLIA: 05D2043189, NPI: 1174964738, D#: TRF-GENERAL-V5). More information on the Fulgent privacy statement for protection of human subjects can be acquired via request to info@fulgentgenetics.com. Data collection was part of routine clinical care and was therefore exempt from requirements for IRB approval. The results presented in this paper have been deidentified, will not affect the patient\u2019s clinical care, nor have the potential to cause the patient any harm.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}